InvestorsHub Logo
icon url

rosemountbomber

07/21/23 3:08 AM

#412730 RE: Nukemtiltheyglow #412728

Nuke most BOs occur even before FDA approval as the potential of the drug is deemed to be great. Heck Amarin’s stock price was in the 20’s just before approval.

Since that time (a missed opportunity for a BO) Amarin has lost exclusivity for V in the US and showing the world how tough it is to sell the drug. Hence not much interest from BP.

So there will have to be some increase in sales OR convincing BP that in their hands there can be enough sales to return them some profit.